InvestorsObserver
×
News Home

Analyst Rating: Will Gossamer Bio Inc (GOSS) Stock Lead the Market?

Wednesday, February 01, 2023 03:32 PM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Gossamer Bio Inc (GOSS) Stock Lead the Market?

InvestorsObserver is giving Gossamer Bio Inc (GOSS) an Analyst Rating Rank of 47, meaning GOSS is ranked higher by analysts than 47% of stocks. The average price target for GOSS is $7.454 and analyst’s rate the stock as a Strong Buy.

Overall Score - 4.2
Wall Street analysts are rating GOSS a Strong Buy today. Find out what this means to you and get the rest of the rankings on GOSS!

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Gossamer Bio Inc Stock Today?

Gossamer Bio Inc (GOSS) stock is trading at $2.83 as of 3:32 PM on Wednesday, Feb 1, a gain of $0.18, or 7.01% from the previous closing price of $2.64. The stock has traded between $2.52 and $2.84 so far today. Volume today is below average. So far 1,709,121 shares have traded compared to average volume of 5,776,540 shares. Click Here to get the full Stock Report for Gossamer Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App